Inventor
ABRAMS PAUL G
US21 patents
⚠️ This page may combine multiple inventors who share the name “ABRAMS PAUL G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEORX CORP
16 patentsUS5112954AMay 12, 1992
Method of enhancing the effect of cytotoxic agents
NEORX CORP147 citations99
US5169933ADec 8, 1992
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
NEORX CORP409 citations98
US5322678AJun 21, 1994
Alteration of pharmacokinetics of proteins by charge modification
NEORX CORP120 citations96
US4867962ASep 19, 1989
Functionally specific antibodies
NEORX CORP73 citations96
US6767531B2Jul 27, 2004
High dose radionuclide complexes for bone marrow suppression
NEORX CORP29 citations95
US5976535ANov 2, 1999
Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore
NEORX CORP76 citations95
US5171563ADec 15, 1992
Cleavable linkers for the reduction of non-target organ retention of immunoconjugates
NEORX CORP44 citations93
US5135736AAug 4, 1992
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
NEORX CORP98 citations93
US7097823B2Aug 29, 2006
High dose radionuclide complexes for bone marrow suppression
NEORX CORP13 citations91
USRE38008EFeb 25, 2003
Methods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereof
NEORX CORP42 citations91
US5034223AJul 23, 1991
Methods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereof
NEORX CORP51 citations91
US5078673AJan 7, 1992
Selective removal of radiolabeled antibodies
NEORX CORP21 citations82
US7070759B2Jul 4, 2006
High dose radionuclide complexes for bone marrow suppression
NEORX CORP9 citations72
US5635180AJun 3, 1997
Alteration of pharmacokinetics of proteins by charge modification
NEORX CORP14 citations72
US5157104AOct 20, 1992
Trichothecene conjugates
NEORX CORP1 citations60
US4822734AApr 18, 1989
Method for improving the elicitation of IgG class monoclonal antibodies to tumor-associated antigens and glycoproteins
NEORX CORP4 citations60